When is the best time to draw women's hormone levels, specifically Follicle-Stimulating Hormone (FSH), to evaluate menopause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Time to Draw Hormone Levels for Menopause Evaluation

The best time to draw women's hormone levels, specifically Follicle-Stimulating Hormone (FSH), to evaluate menopause is during the early follicular phase (days 2-5 of the menstrual cycle) for women who are still menstruating, while timing is not critical for women with amenorrhea of 12 months or more. 1

Diagnostic Criteria for Menopause

Menopause is clinically defined as 12 consecutive months without menstruation, with natural menopause occurring at a median age of 51 years in the United States (normal range 40-60 years). The diagnostic criteria include:

  • Age ≥ 60 years
  • Amenorrhea ≥ 12 months
  • FSH levels > 40 IU/L
  • Estradiol levels < 30 pg/mL
  • Clinical symptoms (vasomotor symptoms, vaginal dryness, sleep disturbances, etc.) 1

Hormone Testing Recommendations

For Women with Irregular Cycles (Perimenopause):

  • Draw FSH during early follicular phase (days 2-5 of the menstrual cycle)
  • If oligomenorrhoea is present, measure during early follicular phase (day 2-5)
  • If amenorrhea is present, FSH and estradiol can be measured randomly 2

For Women with Amenorrhea:

  • For women with amenorrhea of 12 months or more, FSH can be drawn at any time
  • Two elevated serum FSH levels in the menopausal range are needed for diagnosis of premature ovarian insufficiency 2

Important Considerations for FSH Testing

  1. Limitations of FSH testing in perimenopause:

    • FSH levels fluctuate markedly during perimenopause, making a single measurement unreliable 3, 4
    • FSH can rise into postmenopausal range and then fall back to premenopausal range during the menopausal transition 4
    • Ovulatory cycles may still occur despite postmenopausal FSH levels 4
  2. More reliable diagnosis:

    • Two elevated FSH measurements are more reliable than one 2
    • FSH > 40 IU/L combined with estradiol < 30 pg/mL provides stronger evidence of menopause 1
    • Clinical symptoms and menstrual history should be considered alongside laboratory values 5
  3. Timing considerations:

    • Stop oral contraceptives/hormone therapy ideally two months before testing for accurate results 2
    • Morning samples are preferred for consistency

Practical Algorithm for FSH Testing

  1. For women aged 40-60 with irregular cycles:

    • Draw FSH and estradiol on day 2-5 of menstrual cycle
    • If FSH > 40 IU/L and estradiol < 30 pg/mL, suggestive of perimenopause/menopause
    • Repeat test in 2-3 months if results are inconclusive
  2. For women with amenorrhea:

    • Draw FSH and estradiol at any time
    • If amenorrhea has persisted for 12 months and FSH > 40 IU/L, diagnosis of menopause is confirmed
    • For women < 40 years with elevated FSH, repeat testing to confirm premature ovarian insufficiency
  3. For women on hormonal contraception:

    • Discontinue hormonal contraception for at least 2 months before testing
    • Then follow protocol based on menstrual pattern

Cautions and Pitfalls

  • A single FSH measurement is not reliable for diagnosing menopause, especially during the menopausal transition 3, 4
  • FSH levels can fluctuate significantly during perimenopause, with levels sometimes temporarily reaching postmenopausal range 4
  • Serum FSH and/or estradiol levels are not accurate enough by themselves to rule in or rule out perimenopause 5
  • Clinical diagnosis based on menstrual history and age is often more reliable than laboratory testing alone 5
  • Women should continue contraception until menopause is confirmed, as pregnancies can still occur despite elevated FSH levels 2, 4

Remember that no reliable laboratory tests are available to confirm definitive loss of fertility in a woman, and assessment of FSH levels to determine when a woman is no longer fertile might not be accurate 2.

References

Guideline

Menopause Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.